Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05333289 · ClinicalTrials.gov registry record · Phase 1

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

A Phase 1 study of Seasonal Influenza, sponsored by ModernaTX.

Completed
Registry status
Phase 1
Development phase
572
Enrollment target
15
Study locations

NCT05333289 is a Phase 1 study of Seasonal Influenza that has completed, run by ModernaTX. The registered enrollment target is 572 participants, above the 260-participant average among 3 other Seasonal Influenza trials with a reported enrollment target (120% higher). The trial reports 15 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05333289, a Phase 1 study of Seasonal Influenza, has completed, sponsored by ModernaTX.

COMPLETED
Registry status
Phase 1
Development phase
572 participants
Enrollment target
15
Study locations

Study Summary

The primary objective of this study is to evaluate the safety, reactogenicity, and humoral immunogenicity of mRNA-1020, mRNA-1030, and mRNA-1010 vaccines against vaccine-matched influenza A and B strains.

Conditions Studied

Seasonal Influenza

Interventions

  • BIOLOGICAL mRNA-1030
  • BIOLOGICAL mRNA-1020
  • BIOLOGICAL mRNA-1010
  • BIOLOGICAL Active Comparator

Study Locations (15)

Florida

  • Alliance for MultiSpecialty Research - Coral Gables
  • Health Awareness, Inc. - Jupiter

North Carolina

  • Lucas Research - Morehead City
  • Trial Management Associates, LLC - Wilmington

Utah

  • Olympus Family Medicine - Salt Lake City
  • South Ogden Family Medicine - South Ogden

Arizona

  • Foothills Research Center - Phoenix

Georgia

  • IACT Health - Columbus

Iowa

  • Meridian Clinical Research - Sioux City

Kansas

  • Heartland Research Associates, LLC - Wichita

Missouri

  • Sundance Clinical Research, LLC - St Louis

Trial Details

FieldValue
Enrollment Target 572 participants
Start Date 2022-04-06
Est. Completion 2022-11-22
Phase Phase 1

Sponsor

ModernaTX

90 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05333289

The ClinicalTrials.gov registry entry for NCT05333289 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 572 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 260-participant average among 3 other Seasonal Influenza trials with a reported enrollment target (120% higher). The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Seasonal Influenza appearing as the primary indexed condition, and to 4 interventions - of which mRNA-1030 is the first listed.

NCT05333289 reports 15 study locations spanning 12 distinct geographic areas - top geographies include Florida, North Carolina, Utah.

Frequently Asked Questions

What is clinical trial NCT05333289 about?

NCT05333289 is a clinical study titled "A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults". The primary objective of this study is to evaluate the safety, reactogenicity, and humoral immunogenicity of mRNA-1020, mRNA-1030, and mRNA-1010 vaccines against vaccine-matched influenza A and B strains.

What is the current status of trial NCT05333289?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 572 participants. The study started on 2022-04-06. Estimated completion is 2022-11-22.

What conditions does trial NCT05333289 study?

This clinical trial studies the following conditions: Seasonal Influenza.

What interventions are being tested in trial NCT05333289?

The interventions under investigation include: mRNA-1030 (BIOLOGICAL), mRNA-1020 (BIOLOGICAL), mRNA-1010 (BIOLOGICAL), Active Comparator (BIOLOGICAL).

Who is sponsoring clinical trial NCT05333289?

This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05333289 being conducted?

This trial has 15 study locations across Arizona, Florida, Georgia, Iowa, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Seasonal Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Seasonal Influenza

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.